Reversion of radiosensitivity in azacytidine-treated XRS5 cells does not result in full radioprotection by WR-1065. [electronic resource]
- International journal of radiation oncology, biology, physics 1992
- 999-1002 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0360-3016
10.1016/0360-3016(92)90905-w doi
Animals Azacitidine--pharmacology CHO Cells Cell Line Cricetinae Mercaptoethylamines--pharmacology Radiation Tolerance Radiation-Protective Agents--pharmacology